184 related articles for article (PubMed ID: 24035689)
1. Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate (HDMTX).
Cohen IJ
Med Hypotheses; 2013 Nov; 81(5):942-7. PubMed ID: 24035689
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.
Cohen IJ
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1057-1065. PubMed ID: 28455583
[TBL] [Abstract][Full Text] [Related]
3. Defining the appropriate dosage of folinic acid after high-dose methotrexate for childhood acute lymphatic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous system.
Cohen IJ
J Pediatr Hematol Oncol; 2004 Mar; 26(3):156-63. PubMed ID: 15125607
[TBL] [Abstract][Full Text] [Related]
4. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
[TBL] [Abstract][Full Text] [Related]
5. How long can folinic acid rescue be delayed after high-dose methotrexate without toxicity?
Cohen IJ; Wolff JE
Pediatr Blood Cancer; 2014 Jan; 61(1):7-10. PubMed ID: 24038885
[TBL] [Abstract][Full Text] [Related]
6. Prevention of high-dose-methotrexate neurotoxicity by adequate folinic acid rescue is possible even after central nervous system irradiation.
Cohen IJ
Med Hypotheses; 2007; 68(5):1147-53. PubMed ID: 17270361
[TBL] [Abstract][Full Text] [Related]
7. Histological Effect of Methotrexate and Folinic Acid on Oral Epithelium of Albino Rats.
Ahmad A; Kazi MS
J Coll Physicians Surg Pak; 2016 Jun; 26(6):455-8. PubMed ID: 27353978
[TBL] [Abstract][Full Text] [Related]
8. Concepts in use of high-dose methotrexate therapy.
Treon SP; Chabner BA
Clin Chem; 1996 Aug; 42(8 Pt 2):1322-9. PubMed ID: 8697606
[TBL] [Abstract][Full Text] [Related]
9. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
[TBL] [Abstract][Full Text] [Related]
10. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
Sterba J; Valík D; Bajciová V; Kadlecová V; Gregorová V; Mendelová D
Neoplasma; 2005; 52(6):456-63. PubMed ID: 16284689
[TBL] [Abstract][Full Text] [Related]
11. Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
Heuschkel S; Kretschmann T; Teipel R; von Bonin S; Richter S; Quick S; Alakel N; Röllig C; Balaian E; Kroschinsky F; Knoth H; Bornhäuser M; von Bonin M
Cancer Chemother Pharmacol; 2022 Jan; 89(1):41-48. PubMed ID: 34669022
[TBL] [Abstract][Full Text] [Related]
12. The correlation between dose of folinic acid and neurotoxicity in children and adolescents treated for osteosarcoma with high-dose methotrexate (HDMTX): a neuropsychological and psychosocial study.
Bonda-Shkedi E; Arush MW; Kaplinsky C; Ash S; Goshen Y; Yaniv I; Cohen IJ
J Pediatr Hematol Oncol; 2013 May; 35(4):271-5. PubMed ID: 23612378
[TBL] [Abstract][Full Text] [Related]
13. Leucovorin (folinic acid) rescue for high-dose methotrexate: A review.
Jiang R; Mei S; Zhao Z
J Clin Pharm Ther; 2022 Sep; 47(9):1452-1460. PubMed ID: 35929573
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
Wolfrom C; Hepp R; Hartmann R; Breithaupt H; Henze G
Eur J Clin Pharmacol; 1990; 39(4):377-83. PubMed ID: 2076721
[TBL] [Abstract][Full Text] [Related]
15. Bayesian population model of methotrexate to guide dosage adjustments for folate rescue in patients with breast cancer.
Monjanel-Mouterde S; Lejeune C; Ciccolini J; Merite N; Hadjaj D; Bonnier P; Piana P; Durand A
J Clin Pharm Ther; 2002 Jun; 27(3):189-95. PubMed ID: 12081632
[TBL] [Abstract][Full Text] [Related]
16. 5-fluorouracil modulates the toxicity of high dose methotrexate.
White RM
J Clin Pharmacol; 1995 Dec; 35(12):1156-65. PubMed ID: 8750366
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of folinic acid on low-dose methotrexate genotoxicity.
Shahin AA; Ismail MM; Saleh AM; Moustafa HA; Aboul-Ella AA; Gabr HM
Z Rheumatol; 2001 Apr; 60(2):63-8. PubMed ID: 11383050
[TBL] [Abstract][Full Text] [Related]
18. Reduced dose folinic acid rescue after rapid high-dose methotrexate clearance is not associated with increased toxicity in a pediatric cohort.
Niinimäki R; Aarnivala H; Banerjee J; Pokka T; Vepsäläinen K; Harila-Saari A
Support Care Cancer; 2022 Jan; 30(1):127-133. PubMed ID: 34235555
[TBL] [Abstract][Full Text] [Related]
19. Early, empiric high-dose leucovorin rescue in lymphoma patients treated with sequential doses of high-dose methotrexate.
Barreto JN; Peterson KT; Barreto EF; Mara KC; Dierkhising RA; Leung N; Witzig TE; Thompson CA
Support Care Cancer; 2021 Sep; 29(9):5293-5301. PubMed ID: 33661366
[TBL] [Abstract][Full Text] [Related]
20. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
